rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1999-1-26
|
pubmed:abstractText |
A new bivalent ligand of formula 3 which results from the covalent coupling of two sumatriptan molecules with a p-xylyl spacer at the level of the sulfonamide nitrogen has been prepared and evaluated as a 5-HT1B/1D receptors agonist. In vitro experiments at 5-HT1B human cloned receptors (Ki = 0.64 nM; EC50 = 0.58 nM) and at the level of the contraction of the New Zealand white rabbit saphenous vein (pD2 = 6.6) demonstrate the superior potency of dimer 3 as a 5-HT1B receptor agonist when compared to sumatriptan or zolmitriptan. Interestingly enough, the new bivalent agonist 3 was found to induce hypothermia in the guineapig upon oral administration suggesting good oral activity and access to the brain.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0960-894X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
675-80
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9871581-Animals,
pubmed-meshheading:9871581-Cell Line,
pubmed-meshheading:9871581-Dimerization,
pubmed-meshheading:9871581-Drug Design,
pubmed-meshheading:9871581-Guinea Pigs,
pubmed-meshheading:9871581-Humans,
pubmed-meshheading:9871581-Models, Chemical,
pubmed-meshheading:9871581-Rabbits,
pubmed-meshheading:9871581-Receptor, Serotonin, 5-HT1B,
pubmed-meshheading:9871581-Receptors, Serotonin,
pubmed-meshheading:9871581-Serotonin Receptor Agonists,
pubmed-meshheading:9871581-Sumatriptan
|
pubmed:year |
1998
|
pubmed:articleTitle |
Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist.
|
pubmed:affiliation |
Medicinal Chemistry Division, Centre de Recherche Pierre FABRE, Castres, France.
|
pubmed:publicationType |
Journal Article
|